NF-κB is recognized as a key transcription factor in regulating inflammation-related gene expression [35], as well as PD-L1 expression in lung cancer [36], thereby enhancing the metastatic potentials of TNBC [37,38,39]. The gene discussed is NFKB1; the disease is lung cancer.